AURINIA PHARMACEUTICALS INC COM NPV revenue for the last year amounted to 232.62 M CAD, the most of which — 232.62 M CAD — came from its highest performing source at the moment, Therapeutic Drugs, the year earlier bringing 181.69 M CAD. The greatest contribution to the revenue figure was made by United States — last year it brought AURINIA PHARMACEUTICALS INC COM NPV 209.35 M CAD, and the year before that — 138.89 M CAD.